Pharming (PHAR) Other Non-Current Assets (2019 - 2025)

Pharming's Other Non-Current Assets history spans 7 years, with the latest figure at $2.0 million for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $2.0 million for Q4 2025, up 32.89% from a year ago — trailing twelve months through Dec 2025 was $2.0 million (up 32.89% YoY), and the annual figure for FY2025 was $2.0 million, up 32.89%.
  • Other Non-Current Assets for Q4 2025 was $2.0 million at Pharming, up from $1.5 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $2.0 million in Q4 2025 to a low of $228000.0 in Q4 2022.
  • The 5-year median for Other Non-Current Assets is $1.5 million (2024), against an average of $1.3 million.
  • The sharpest move saw Other Non-Current Assets crashed 77.2% in 2022, then skyrocketed 570.18% in 2023.
  • Year by year, Other Non-Current Assets stood at $1.0 million in 2021, then crashed by 77.2% to $228000.0 in 2022, then skyrocketed by 570.18% to $1.5 million in 2023, then dropped by 1.51% to $1.5 million in 2024, then soared by 32.89% to $2.0 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $2.0 million, $1.5 million, and $1.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.